Clinical Trials Logo

Rhinitis clinical trials

View clinical trials related to Rhinitis.

Filter by:

NCT ID: NCT03282630 Completed - Patients Clinical Trials

The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis

Start date: January 16, 2016
Phase: N/A
Study type: Interventional

Sphenopalatine ganglion (SPG)-acupuncture has been shown to exhibit distinct effects in treatment of nasal inflammatory disease. Investigators aimed to assess the effects of SPG acupuncture in patients with seasonal allergic rhinitis. The randomized, double-blind, controlled clinical trial enrolled participants with seasonal allergic rhinitis. Participants will be randomly assigned to either active SPG-acupuncture group or sham-acupuncture group. All participants will be provided four times of acupuncture in 4 weeks, and then follow-up of 4 week. Primary trial outcomes are change in symptoms and change in need for medication. The primary outcomes will be measured in baseline, week1, week2, week3, week4, week 6 and week 8. Secondary outcomes include the changes in nasal patency (nasal airway resistance and nasal cavity volume), exhaled nasal nitric oxide.The investigators also evaluate change in neuropeptides (substance P, vasoactive intestinal peptide,neuropeptide Y) and inflammatory cytokines (interleukin(IL)-4, IL-5, IL-8, IL-17a, IL-22, IL-25, interferon-γ, tumor necrosis factor-α, transforming growth factor(TGF)-β1, TGF-β2, TGF-β3,Chemokine, Eotaxin) in nasal secretions as secondary outcomes. The secondary outcomes will be measured in baseline, week1, week4 and week 8.

NCT ID: NCT03276416 Completed - Asthma Clinical Trials

RAPP-children, Rhinitis & Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis

RAPP
Start date: January 10, 2018
Phase:
Study type: Observational

This observational study aims at developing and validating a simple questionnaire to be routinely applied in the clinical practice, for the evaluation of the quality of life in children with concomitant asthma and allergic rhinitis. The study consists of two phases: Phase 1: Development of the RAPP-children questionnaire starting from the validated RHINASTHMA-children questionnaire. Phase 2: Administration and validation of the RAPP-children questionnaire. 150 children with concomitant asthma and allergic rhinitis will be followed-up for one month. Both at baseline and after one month, the RAPP children and several other standardized questionnaires will be administered.

NCT ID: NCT03251157 Completed - Asthma Clinical Trials

Dietary Intake in Adults From the GA2LEN Folow-up Survey

Start date: January 1, 2007
Phase: N/A
Study type: Observational

The Nutrition Study of the GA2LEN Follow-Survey was designed to investigate the association between usual dietary intake and allergic and respiratory outcomes in adults across Europe. Within this framework, a food frequency questionnaire (FFQ) was designed to ascertain usual dietary intake of 250 food items, which was translated into the languages of the participant centres. Information on daily intake of foods, nutrients, and flavonoids was derived.

NCT ID: NCT03181594 Completed - Chronic Rhinitis Clinical Trials

Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis

FROST
Start date: March 2, 2017
Phase: N/A
Study type: Interventional

A multi-center, prospective, non-randomized, interventional clinical trial to assess the safety and effectiveness of the ClariFix™ device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.

NCT ID: NCT03157505 Completed - Allergic Rhinitis Clinical Trials

Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis

LARbirch
Start date: January 5, 2014
Phase: Phase 3
Study type: Interventional

Local allergic rhinitis (LAR) is relatively new disease. The question of effect of allergen specific immunotherapy on LAR is open. The randomized, double blind placebo controlled trial of birch subcutaneous AIT on LAR were performed in twenty eight patients. The therapy was performed during 24 months in proportion 15 patients with AIT and 13 placebo. The primary endpoint was decreased of symptoms medication score (SMS). Additionally monitoring serum specific IgE, specific IgG4 and nasal specific IgE (nsIgE) to Bet v1 and parameters of safety and quality of life were provided.

NCT ID: NCT03127436 Completed - Clinical trials for Perennial Allergic Rhinitis

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Start date: March 1, 2017
Phase:
Study type: Observational [Patient Registry]

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT therapy With Acarovac® Hausstaubmilbe

NCT ID: NCT03112330 Completed - Atrophic Rhinitis Clinical Trials

A Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Atrophic Rhinitis

ARPRP
Start date: June 8, 2017
Phase: N/A
Study type: Interventional

The goal of the suggested research is to develop a treatment option using platelet rich plasma injection for regeneration of atropic nasal mucosa. Specific aims of the suggested research is to (1) access the effect of platelet rich plasma in the patients with atropic rhinitis . Moreover, we will (2) compare the conservative treatments including saline nasal irrigation or saline nasal spray.

NCT ID: NCT03112252 Completed - Allergic Rhinitis Clinical Trials

App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season

Start date: April 19, 2017
Phase: N/A
Study type: Observational

App-based study of allergy patients under medication in the pollen season to determine the effect of allergic rhinitis on the quality of life.

NCT ID: NCT03101618 Completed - Asthma Clinical Trials

Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers

Start date: August 24, 2016
Phase:
Study type: Observational

The investigators surveyed the prevalence of animal allergy and sensitization to animal allergen among participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and companion animal exhibition (pet owner and pet-related industry workers).

NCT ID: NCT03101267 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

A Dose-finding Study of ASP4070

Start date: April 13, 2017
Phase: Phase 2
Study type: Interventional

The objective of this study was to evaluate the efficacy, safety, and dose-response of ASP4070 vaccinated in patients with cedar pollinosis.